NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ:089140)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,770.00
+65.00 (2.40%)
Last updated: May 12, 2025

NEXTURNBIOSCIENCE Revenue

In the year 2024, NEXTURNBIOSCIENCE had annual revenue of 31.64B KRW, down -23.31%. NEXTURNBIOSCIENCE had revenue of 7.63B in the quarter ending December 31, 2024, a decrease of -35.61%.

Revenue
31.64B
Revenue Growth
-23.31%
P/S Ratio
1.14
Revenue / Employee
555.09M
Employees
57
Market Cap
35.99B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202431.64B-9.62B-23.31%
Dec 31, 202341.26B17.79B75.84%
Dec 31, 202223.46B6.49B38.24%
Dec 31, 202116.97B7.29B75.24%
Dec 31, 20209.69B-15.43B-61.43%
Dec 31, 2010 Pro Pro Pro
Dec 31, 2009 Pro Pro Pro
Dec 31, 2008 Pro Pro Pro
Dec 31, 2007 Pro Pro Pro
Dec 31, 2006 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 308.07T
SK hynix 71.40T
LG Energy Solution 25.76T
Samsung Biologics 4,547.32B
Hyundai Motor Company 178.98T
Hanwha Aerospace 11.24T
Kia Corporation 107.45T
HD Hyundai Heavy Industries 14.49T
Revenue Rankings